Skip to main content

Table 3 Cardiovascular complications and outcomes by sex

From: Biochemical differences based on sex and clusters of biomarkers in patients with COVID-19: analysis from the CARDIO COVID 19–20 registry

Variable

 

Sex

p-value2

 

n = 3,2601

Female, n = 1,2011

Male, n = 2,0591

 

Complications

 Acute coronary syndrome

94 (2.90%)

26 (2.20%)

68 (3.30%)

0.08

 Heart failure

278 (8.50%)

94 (7.80%)

184 (8.90%)

0.3

 Cardiac arrhythmia

68 (3.30%)

90 (7.50%)

206 (10.00%)

0.019

 Myocarditis

40 (1.20%)

16 (1.30%)

24 (1.20%)

0.8

 Pulmonary embolism

126 (3.90%)

35 (2.90%)

91 (4.40%)

0.040

 Deep vein thrombosis

40 (1.20%)

10 (0.80%)

30 (1.50%)

0.2

 Arterial thrombosis

21 (0.60%)

4 (0.30%)

17 (0.80%)

0.14

Outcomes and discharge status

 Intensive Care Unit

1,745 (53.50%)

573 (47.70%)

1,172 (56.90%)

 < 0.001

 Death

831 (25.50%)

266 (22.10%)

565 (27.50%)

0.003

  1. 1n (%)
  2. 2Pearson's Chi-squared test